Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.


Posted on: 03 Jul 18

FIT Biotech Oy                                                                                              

Press Release July 3rd 2018, 08.30 EET

FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

FIT Biotech's half-year financial report will be webcasted on September 6th 2018, at 10.00 AM.

The webcast can be followed in the following link: https://www.inderes.fi/videot/fit-biotech-webcast-2018-puolivuosikatsaus-692018-1000-alkaen

Additional information:
CEO Erkki Pekkarinen
Phone +358 44 027 0080
email: erkki.pekkarinen@fitbiotech.com

About FIT Biotech
FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION:
Principal media
www.fitbiotech.fi

GlobeNewswire
globenewswire.com

Last updated on: 03/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.